BREAKING WEATHER:  AIRPORT DELAYS
Most-prescribed drug in the U.S. recalled: Find out if you are impacted
(Our product safety information is produced by our editors and some content sourced from information provided by the respective company directly and government regulatory agencies. If this is a recall we encourage you to contact the company directly for complete information.)

If you or someone you know takes atorvastatin, a widely prescribed medication used to lower cholesterol and reduce the risk of heart disease, it's important to take action. Due to a recent nationwide recall, certain batches may not dissolve properly, potentially impacting how well the drug works.

Check your prescription label for the NDC (National Drug Code) and lot number, which are typically printed on the pharmacy bottle or packaging. Then consult your pharmacist or healthcare provider to confirm whether your medication is part of the recall and discuss any necessary next steps.

Atorvastatin is one of the most-prescribed drugs in the U.S., so even if you haven't noticed any issues, it's worth verifying to ensure your treatment remains safe and effective.

Drug Recall Summary: Atorvastatin Calcium Tablets (Event ID: 97639)

Recall Overview

Initiated By: Ascend Laboratories, LLC (Voluntary)

Recall Date: September 19, 2025

Status: Ongoing

Notification Method: Letter to consignees

Distribution: Nationwide (U.S.)

Classification: Class II (use may cause temporary or medically reversible adverse health consequences)

Affected Product

Drug: Atorvastatin Calcium Tablets USP (used to lower cholesterol)

Strengths & NDCs:

10 mg (NDCs: 67877-511-90, -511-05, -511-10)

20 mg (NDCs: 67877-512-90, -512-05, -512-10)

40 mg (NDCs: 67877-513-90, -513-05, -513-10)

80 mg (NDCs: 67877-514-90, -514-05)

Manufacturer: Alkem Laboratories, Ltd. (India)

Distributor: Ascend Laboratories, LLC (Parsippany, NJ)

Reason for Recall

Issue: Failed dissolution specifications -- the tablets may not dissolve properly, potentially affecting drug absorption and efficacy.

Lot Numbers & Expiration Dates

Multiple lots across all strengths with expiration dates ranging from July 2026 to February 2027 are impacted.

Quantity Recalled

Over 140,000 bottles of the 10 mg strength alone; quantities for other strengths not disclosed.

If you or someone you know takes atorvastatin, a widely prescribed medication used to lower cholesterol and reduce the risk of heart disease, it's important to take action. Due to a recent nationwide recall, certain batches may not dissolve properly, potentially impacting how well the drug works.

Check your prescription label for the NDC (National Drug Code) and lot number, which are typically printed on the pharmacy bottle or packaging. Then consult your pharmacist or healthcare provider to confirm whether your medication is part of the recall and discuss any necessary next steps.

Atorvastatin is one of the most-prescribed drugs in the U.S., so even if you haven't noticed any issues, it's worth verifying to ensure your treatment remains safe and effective.

Drug Recall Summary: Atorvastatin Calcium Tablets (Event ID: 97639)

Recall Overview

Initiated By: Ascend Laboratories, LLC (Voluntary)

Recall Date: September 19, 2025

Status: Ongoing

Notification Method: Letter to consignees

Distribution: Nationwide (U.S.)

Classification: Class II (use may cause temporary or medically reversible adverse health consequences)

Affected Product

Drug: Atorvastatin Calcium Tablets USP (used to lower cholesterol)

Strengths & NDCs:

10 mg (NDCs: 67877-511-90, -511-05, -511-10)

20 mg (NDCs: 67877-512-90, -512-05, -512-10)

40 mg (NDCs: 67877-513-90, -513-05, -513-10)

80 mg (NDCs: 67877-514-90, -514-05)

Manufacturer: Alkem Laboratories, Ltd. (India)

Distributor: Ascend Laboratories, LLC (Parsippany, NJ)

Reason for Recall

Issue: Failed dissolution specifications -- the tablets may not dissolve properly, potentially affecting drug absorption and efficacy.

Lot Numbers & Expiration Dates

Multiple lots across all strengths with expiration dates ranging from July 2026 to February 2027 are impacted.

Quantity Recalled

Over 140,000 bottles of the 10 mg strength alone; quantities for other strengths not disclosed.